Brent Bailey has commenced his positions as President and Chief Executive Officer of Cyanotech Corporation (nasdaq capital market:CYAN). He was named to those positions and as a Director of the Company by the Board of Directors on November 8, 2010. Mr. Bailey brings nearly 30 years' experience as an operating executive, in leadership and marketing roles, and a consistent track record of profitably building nutritional supplement, food and personal care businesses.
He replaces David I. Rosenthal, who served as Interim President and CEO since February 27, 2010. Mr. Rosenthal remains a Director, in which position he has served since November 2000.
Cyanotech Corporation, a world leader in microalgae technology, produces BioAstin(R) Natural Astaxanthin and Hawaiian Spirulina Pacifica(R)—all natural, functional nutrients that leverage our experience and reputation for quality, building nutritional brands which promote health and well-being. Cyanotech's Spirulina products offer complete nutrition, and augment energy and immune response. They are FDA reviewed and accepted as Generally Recognized as Safe (GRAS) for use in food products. BioAstin's superior antioxidant activity and ability to support and maintain a natural anti-inflammatory response enhance skin, muscle and joint health. All Cyanotech products are produced from microalgae grown at its 90-acre facility in Kona, Hawaii using patented and proprietary technology. Cyanotech distributes to nutritional supplement, nutraceutical and cosmeceutical manufacturers and marketers in more than 54 countries worldwide. Cyanotech was the first microalgae company in the world to obtain quality management standards ISO 9001:2000 certifications and is GMP-certified by the Natural Products Association(TM). Visit www.cyanotech.com for more information.